Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)
China flag China · Delayed Price · Currency is CNY
18.40
-0.35 (-1.87%)
Apr 21, 2026, 3:04 PM CST

SHE:300653 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
364.09362.93413.35432.95399.9
Other Revenue
0.050.290.30.270.28
364.14363.23413.65433.22400.18
Revenue Growth (YoY)
0.25%-12.19%-4.52%8.26%36.45%
Cost of Revenue
51.4344.8942.9849.8744.42
Gross Profit
312.71318.34370.67383.35355.75
Selling, General & Admin
177.18147.9132.04145.55151.39
Research & Development
57.3339.5244.0537.5535.18
Other Operating Expenses
5.163.93.863.873.93
Operating Expenses
239.93191.71180187.24190.84
Operating Income
72.78126.63190.68196.12164.91
Interest Expense
-0.01-0.01-0.01-0-
Interest & Investment Income
8.8213.3818.910.91.72
Other Non Operating Income (Expenses)
-0.03-0.21-0.340.19-0.04
EBT Excluding Unusual Items
81.57139.78209.23207.21166.59
Gain (Loss) on Sale of Investments
5.115.437.3-2.7915.94
Gain (Loss) on Sale of Assets
-0.06-0.080.02-0.92-
Asset Writedown
---0.12-0.11-0.19
Other Unusual Items
1.517.241.978.739.23
Pretax Income
88.13152.38218.4212.11191.58
Income Tax Expense
5.7217.7427.4426.6723.03
Net Income
82.41134.64190.96185.44168.55
Net Income to Common
82.41134.64190.96185.44168.55
Net Income Growth
-38.79%-29.49%2.98%10.02%42.44%
Shares Outstanding (Basic)
179180180145179
Shares Outstanding (Diluted)
179180180145179
Shares Change (YoY)
-0.20%-0.35%24.35%-19.21%0.01%
EPS (Basic)
0.460.751.061.280.94
EPS (Diluted)
0.460.751.061.280.94
EPS Growth
-38.67%-29.24%-17.19%36.17%42.42%
Free Cash Flow
88.09135.81148.6131.78156.31
Free Cash Flow Per Share
0.490.760.820.910.87
Dividend Per Share
0.2800.4600.8020.6000.587
Dividend Growth
-39.13%-42.63%33.63%2.27%251.95%
Gross Margin
85.88%87.64%89.61%88.49%88.90%
Operating Margin
19.99%34.86%46.10%45.27%41.21%
Profit Margin
22.63%37.07%46.16%42.80%42.12%
Free Cash Flow Margin
24.19%37.39%35.92%30.42%39.06%
EBITDA
95.09149.22211.19215.22182.65
EBITDA Margin
26.11%41.08%51.06%49.68%45.64%
D&A For EBITDA
22.3122.5920.5219.117.74
EBIT
72.78126.63190.68196.12164.91
EBIT Margin
19.99%34.86%46.10%45.27%41.21%
Effective Tax Rate
6.49%11.64%12.56%12.57%12.02%
Revenue as Reported
364.14363.23413.65433.22400.18
Advertising Expenses
1.924.193.334.065.11
Source: S&P Global Market Intelligence. Standard template. Financial Sources.